Effect of Timing of Proton Pump Inhibitor Administration on Acid Suppression

被引:7
作者
Furuta, Kenji [1 ]
Adachi, Kyoichi [2 ]
Aimi, Masahito [1 ]
Shimura, Shino [1 ]
Mikami, Hironobu [1 ]
Nishimura, Nobuhiro [3 ]
Ishimura, Norihisa [1 ]
Ishihara, Shunji [1 ]
Naora, Kohji [3 ]
Kinoshita, Yoshikazu [1 ]
机构
[1] Shimane Univ, Sch Med, Dept Internal Med 2, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan
[2] Shimane Environm & Hlth Public Corp, Ctr Hlth, Koshihara, Shimane, Japan
[3] Shimane Univ Hosp, Dept Pharm, Koshihara, Shimane, Japan
关键词
Esomeprazole; Rabeprazole; Administration time; Acid inhibition; GASTROESOPHAGEAL-REFLUX DISEASE; INTRAGASTRIC PH; DOUBLE-BLIND; CROSS-OVER; ESOMEPRAZOLE; MANAGEMENT; JAPANESE; PHARMACOKINETICS; RABEPRAZOLE; DIAGNOSIS;
D O I
10.1159/000441972
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Esomeprazole has been reported to show a strong acid suppression following preprandial as compared to postprandial administration, though no known study has compared the acid suppressing effects of other proton pump inhibitors between those administrations. The aim of this study was to compare intragastric pH levels following pre- and postprandial administrations of rabeprazole and esomeprazole. Methods: In 15 Helicobacter pylori-negative healthy volunteers, we measured intragastric pH after 7 days of pre- and postprandial administrations of rabeprazole (10 mg) or esomeprazole (20 mg) using a 5-way crossover design. Results: Preprandial administration of esomeprazole showed stronger acid suppression than postprandial administration. The values for percent time at pH >4.0 over a 24-hour period increased from 45.3% with postprandial administration of esomeprazole to 54.4% with preprandial administration, while the percent time at pH >4.0 during daytime was increased to a greater extent from 51.4 to 66.5% with preprandial administration (p = 0.05). On the other hand, the acid suppressing effect of rabeprazole was not influenced by the timing of administration. Conclusions: The acid suppressing effect of esomeprazole is influenced by administration timing. In contrast, the acid suppressing effect of rabeprazole is not augmented by preprandial administration. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:111 / 120
页数:10
相关论文
共 27 条
[1]   Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection [J].
Adachi, K ;
Kawamura, A ;
Ono, M ;
Masuzaki, K ;
Takashima, T ;
Yuki, M ;
Fujishiro, H ;
Ishihara, S ;
Kinoshita, Y .
JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) :703-708
[2]  
DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594
[3]  
Fass R, 2005, ALIMENT PHARM THER, V22, P79, DOI 10.1111/j.1365-2036.2005.02531.x
[4]   Relationship between the Acid-inhibitory Effects of Two Proton Pump Inhibitors and CYP2C19 Genotype in Japanese Subjects: a Randomized Two-way Crossover Study [J].
Furuta, K. ;
Adachi, K. ;
Ohara, S. ;
Morita, T. ;
Tanimura, T. ;
Koshino, K. ;
Kinoshita, Y. .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (04) :1473-1483
[5]   Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease [J].
Furuta, Kenji ;
Adachi, Kyoichi ;
Komazawa, Yoshinori ;
Mihara, Takafumi ;
Miki, Masaharu ;
Azumi, Takane ;
Fujisawa, Tomoo ;
Katsube, Tomoko ;
Kinoshita, Yoshikazu .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (10) :1581-1585
[6]   Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison [J].
Furuta, Kenji ;
Kohata, Yukie ;
Fujiwara, Yasuhiro ;
Sugimoto, Mitsushige ;
Uotani, Takahiro ;
Yamade, Mihoko ;
Sahara, Shu ;
Ichikawa, Hitomi ;
Furuta, Takahisa ;
Nio, Kenta ;
Iwakiri, Ryuichi ;
Inamori, Masahiko ;
Kawamura, Osamu ;
Kusano, Motoyasu ;
Kato, Mototsugu ;
Kawami, Noriyuki ;
Iwakiri, Katsuhiko ;
Takeuchi, Toshihisa ;
Higuchi, Kazuhide ;
Aimi, Masahito ;
Naora, Kohji ;
Fujimoto, Kazuma ;
Arakawa, Tetsuo ;
Kinoshita, Yoshikazu .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2014, 55 (03) :178-183
[7]  
Gallup Organization, 2000, 2000 GALL STUD CONS
[8]   Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease [J].
Gunaratnam, NT ;
Jessup, TP ;
Inadomi, J ;
Lascewski, DP .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (10) :1473-1477
[9]   Proton pump inhibitors: better acid suppression when taken before a meal than without a meal [J].
Hatlebakk, JG ;
Katz, PO ;
Camacho-Lobato, L ;
Castell, DO .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) :1267-1272
[10]   Step-by-step management of refractory gastresophageal reflux disease [J].
Hershcovici, T. ;
Fass, R. .
DISEASES OF THE ESOPHAGUS, 2013, 26 (01) :27-36